{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T21:21:40Z","timestamp":1791235300234,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.ard.2025.10.019","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T14:50:23Z","timestamp":1763650223000},"page":"497-506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (\u2018Registry\u2019)"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-7320-8427","authenticated-orcid":false,"given":"Jonathan","family":"Thaler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Parides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danieli Castro Oliveira","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Paredes","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria G.","family":"Tektonidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Pengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savino","family":"Sciascia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Nalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme","family":"de Jes\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul R.","family":"Fortin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Efthymiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Michael","family":"Belmont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Petri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricard","family":"Cervera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie","family":"Skeith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chary","family":"L\u00f3pez-Pedrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. Ware","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Kello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhuoli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Rodriguez","family":"Almaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahar","family":"Artim-Esen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Pardos-Gea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Pons-Estel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Pazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Duarte-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Medha","family":"Barbhaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Yelnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Meroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Roubey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Laura","family":"Bertolaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob H.","family":"Rand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7216-677X","authenticated-orcid":false,"given":"Doruk","family":"Erkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ard.2025.10.019_bib0001","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome","volume":"4","author":"Miyakis","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ard.2025.10.019_bib0002","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11926-018-0775-8","article-title":"Primary thrombosis prophylaxis in persistently antiphospholipid antibody-positive individuals: where do we stand in 2018?","volume":"20","author":"Zuo","year":"2018","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ard.2025.10.019_bib0003","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1056\/NEJMra1705454","article-title":"Diagnosis and management of the antiphospholipid syndrome","volume":"378","author":"Garcia","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2025.10.019_bib0004","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11926-021-01008-8","article-title":"Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION): 10-year update","volume":"23","author":"Erkan","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"10.1016\/j.ard.2025.10.019_bib0005","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1002\/acr.24468","article-title":"Characteristics of patients with antiphospholipid antibody positivity in the APS ACTION international clinical database and repository","volume":"74","author":"Sevim","year":"2022","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"suppl 9","key":"10.1016\/j.ard.2025.10.019_bib0006","article-title":"First and recurrent thrombosis risk after 4,454 patient-years of follow-up: prospective results from the Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository [abstract]","volume":"75","author":"Thaler","year":"2023","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 9","key":"10.1016\/j.ard.2025.10.019_bib0007","article-title":"First and recurrent thrombosis risk after 3,842 patient-years of follow-up: prospective results from APS ACTION clinical database and repository [abstract]","volume":"73","author":"Ahmadzadeh","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 9","key":"10.1016\/j.ard.2025.10.019_bib0008","article-title":"First and recurrent thrombosis risk after 1,897 patient-years of follow-up: prospective results from APS ACTION registry [abstract]","volume":"70","author":"Sevim","year":"2018","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 10","key":"10.1016\/j.ard.2025.10.019_bib0009","article-title":"APS ACTION registry analysis: first and recurrent thrombosis risk after 1,201 patient-years of follow-up [abstract]","volume":"69","author":"Unlu","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 10","key":"10.1016\/j.ard.2025.10.019_bib0010","article-title":"APS ACTION registry analysis: first and recurrent thrombosis risk after 720 patient-years of follow-up [abstract]","volume":"68","author":"Unlu","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"suppl 10","key":"10.1016\/j.ard.2025.10.019_bib0011","article-title":"APS ACTION registry prospective follow-up analysis: one-year first and recurrent thrombosis risk [abstract]","volume":"67","author":"Erkan","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.10.019_bib0012","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1111\/jth.15047","article-title":"Guidance from the Scientific and Standardization Committee for lupus anticoagulant\/antiphospholipid antibodies of the ISTH: update of the guidelines for lupus anticoagulant detection and interpretation","volume":"18","author":"Devreese","year":"2020","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ard.2025.10.019_bib0013","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1182\/blood-2017-09-805689","article-title":"Antiphospholipid antibodies and recurrent thrombosis after a first unprovoked venous thromboembolism","volume":"131","author":"Kearon","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.ard.2025.10.019_bib0014","first-page":"120","article-title":"Risk factors for venous and arterial thrombosis","volume":"9","author":"Previtali","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1016\/j.ard.2025.10.019_bib0015","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1001\/archinte.160.6.761","article-title":"Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study","volume":"160","author":"Heit","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ard.2025.10.019_bib0016","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMoa032959","article-title":"The risk of recurrent venous thromboembolism in men and women","volume":"350","author":"Kyrle","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ard.2025.10.019_bib0017","doi-asserted-by":"crossref","first-page":"I9","DOI":"10.1161\/01.CIR.0000078469.07362.E6","article-title":"Risk factors for venous thromboembolism","volume":"107","author":"Anderson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ard.2025.10.019_bib0018","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/bjh.13183","article-title":"New perspectives on the thrombotic complications of haemolysis","volume":"168","author":"L\u2019Acqua","year":"2015","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ard.2025.10.019_bib0019","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1111\/jth.15757","article-title":"Intravascular hemolysis and multitreatment predict thrombosis in patients with autoimmune hemolytic anemia","volume":"20","author":"Fattizzo","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ard.2025.10.019_bib0020","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.thromres.2014.10.012","article-title":"Risk of venous thromboembolism occurrence among adults with selected autoimmune diseases: a study among a U.S. cohort of commercial insurance enrollees","volume":"135","author":"Yusuf","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.ard.2025.10.019_bib0021","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.3324\/haematol.2009.018390","article-title":"Thromboembolic events among adult patients with primary immune thrombocytopenia in the UK General Practice Research Database","volume":"95","author":"Sarpatwari","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.ard.2025.10.019_bib0022","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/ejh.12777","article-title":"Thromboembolism in adults with primary immune thrombocytopenia: a systematic literature review and meta-analysis","volume":"97","author":"Doobaree","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ard.2025.10.019_bib0023","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/0895-4356(95)00510-2","article-title":"Importance of events per independent variable in proportional hazards analysis. I. Background, goals, and general strategy","volume":"48","author":"Concato","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ard.2025.10.019_bib0024","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1093\/aje\/kwk052","article-title":"Relaxing the rule of ten events per variable in logistic and Cox regression","volume":"165","author":"Vittinghoff","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.ard.2025.10.019_bib0025","doi-asserted-by":"crossref","DOI":"10.3324\/haematol.2024.287133","article-title":"Mechanisms sensitive to different drugs mediate a pro-adhesive and pro-thrombotic platelet phenotype in anti-phospholipid syndrome","author":"Camera","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.ard.2025.10.019_bib0026","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1093\/rheumatology\/keac650","article-title":"Thrombocytopaenia in antiphospholipid syndrome: a free radical perspective","volume":"62","author":"Ames","year":"2023","journal-title":"Rheumatology (Oxford)"},{"issue":"suppl 9","key":"10.1016\/j.ard.2025.10.019_bib0027","article-title":"Plasma proteomics analysis identifies thromboinflammatory signature associated with clinical APS: results from APS ACTION registry [abstract]","volume":"76","author":"Pine","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.ard.2025.10.019_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1459842","article-title":"Cell-bound complement activation products in antiphospholipid antibody-positive patients without other systemic autoimmune rheumatic diseases","volume":"15","author":"Erkan","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.ard.2025.10.019_bib0029","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/096120339700600510","article-title":"Risk for venous thrombosis related to antiphospholipid antibodies in SLE\u2014a meta-analysis","volume":"6","author":"Wahl","year":"1997","journal-title":"Lupus"},{"key":"10.1016\/j.ard.2025.10.019_bib0030","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1177\/0961203314545410","article-title":"Persistent antiphospholipid antibody in asymptomatic carriers as a risk factor for future thrombotic events","volume":"23","author":"Mustonen","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.ard.2025.10.019_bib0031","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1002\/art.41891","article-title":"Expert perspective: Management of microvascular and catastrophic antiphospholipid syndrome","volume":"73","author":"Erkan","year":"2021","journal-title":"Arthritis Rheumatol"},{"issue":"Supplement 1","key":"10.1016\/j.ard.2025.10.019_bib0032","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1182\/blood-2023-185232","article-title":"Proteomic profiling of different antiphospholipid antibody-positive phenotypes: Results from Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Registry","volume":"142","author":"Pine","year":"2023","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.ard.2025.10.019_bib0033","doi-asserted-by":"crossref","first-page":"e107","DOI":"10.1097\/RHU.0000000000001961","article-title":"Controversies in the Management of Antiphospholipid Syndrome","volume":"29","author":"Porta","year":"2023","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/j.ard.2025.10.019_bib0034","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1136\/ard-2023-224609","article-title":"2023 ACR\/EULAR antiphospholipid syndrome classification criteria","volume":"82","author":"Barbhaiya","year":"2023","journal-title":"Ann Rheum Dis"},{"issue":"suppl 9","key":"10.1016\/j.ard.2025.10.019_bib0035","article-title":"on behalf of APS ACTION. Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody positive patients: prospective analysis of the international APS ACTION clinical database and repository (\u201cRegistry\u201d) [abstract]","volume":"76","author":"Thaler","year":"2024","journal-title":"Arthritis Rheumatol"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725044589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496725044589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:25:54Z","timestamp":1786191954000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496725044589"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0003496725044589"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2025.10.019","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical and biologic predictors of thrombosis in persistently antiphospholipid antibody-positive patients: Prospective analysis of the International APS ACTION Clinical Database and Repository (\u2018Registry\u2019)","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2025.10.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Alliance of Associations for Rheumatology (EULAR). Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}